108 related articles for article (PubMed ID: 18922379)
1. Re: relief of incident dyspnea in palliative cancer patients.
Cuervo Pinna MA
J Pain Symptom Manage; 2008 Oct; 36(4):e5-6. PubMed ID: 18922379
[No Abstract] [Full Text] [Related]
2. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.
Charles MA; Reymond L; Israel F
J Pain Symptom Manage; 2008 Jul; 36(1):29-38. PubMed ID: 18358689
[TBL] [Abstract][Full Text] [Related]
3. Can we really say that nebulized morphine works?
Lasheen W; Panneerselvam A; Davis MP
J Pain Symptom Manage; 2006 Aug; 32(2):101-2; author reply 102-3. PubMed ID: 16877173
[No Abstract] [Full Text] [Related]
4. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
[TBL] [Abstract][Full Text] [Related]
5. Nebulized hydromorphone for dyspnea in hospice care of advanced cancer.
Sarhill N; Walsh D; Khawam E; Tropiano P; Stahley MK
Am J Hosp Palliat Care; 2000; 17(6):389-91. PubMed ID: 11886040
[TBL] [Abstract][Full Text] [Related]
6. Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease?
Eaton B; Hall J; MacDonald S
Can Fam Physician; 1999 Feb; 45():319-20. PubMed ID: 10065305
[No Abstract] [Full Text] [Related]
7. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.
Philip J; Gold M; Milner A; Di Iulio J; Miller B; Spruyt O
J Pain Symptom Manage; 2006 Dec; 32(6):541-50. PubMed ID: 17157756
[TBL] [Abstract][Full Text] [Related]
9. Nebulized opioids in the treatment of dyspnea.
Quelch PC; Faulkner DE; Yun JW
J Palliat Care; 1997; 13(3):48-52. PubMed ID: 9354041
[No Abstract] [Full Text] [Related]
10. Dose proportionality of the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR).
Durnin C; Hind ID; Ghani SP; Yates DB; Cross M
Proc West Pharmacol Soc; 2001; 44():73-4. PubMed ID: 11794000
[No Abstract] [Full Text] [Related]
11. Effect of food on the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR).
Durnin C; Hind ID; Channon E; Yates DB; Cross M
Proc West Pharmacol Soc; 2001; 44():75-6. PubMed ID: 11794001
[No Abstract] [Full Text] [Related]
12. Nebulized morphine for relief of dyspnea due to chronic lung disease.
Brown SJ; Eichner SF; Jones JR
Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
Clemens KE; Klaschik E
J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in male and female subjects.
Durnin C; Hind ID; Ghani SP; Yates DB; Gegg J
Proc West Pharmacol Soc; 2001; 44():77-8. PubMed ID: 11794002
[No Abstract] [Full Text] [Related]
16. Pressure-pulsed inhalation corticosteroid therapy in olfactory disorders: how we do it.
Fleiner F; Lau L; Goektas O
Clin Otolaryngol; 2010 Oct; 35(5):429-34. PubMed ID: 21108757
[No Abstract] [Full Text] [Related]
17. Opioid withdrawal syndrome on switching from hydromorphone to alfentanil.
McMunnigall F; Welsh J
Palliat Med; 2008 Mar; 22(2):191-2. PubMed ID: 18372384
[TBL] [Abstract][Full Text] [Related]
18. Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients.
Benitez-Rosario MA; Martin AS; Feria M
J Pain Symptom Manage; 2005 Nov; 30(5):395-7. PubMed ID: 16310612
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with renal impairment.
Durnin C; Hind ID; Wickens MM; Yates DB; Molz KH
Proc West Pharmacol Soc; 2001; 44():81-2. PubMed ID: 11794004
[No Abstract] [Full Text] [Related]
20. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
